ConvaTec Group PLC Director/PDMR Shareholding
26 March 2022 - 01:00AM
UK Regulatory (RNS & others)
TIDMCTEC
RNS Number : 1077G
ConvaTec Group PLC
25 March 2022
25 March 2022
ConvaTec Group Plc
("ConvaTec" or "the Company")
Director/PDMR Shareholding
The Company has been notified of the following transaction by a
Person Discharging Managerial Responsibility ("PDMR") in ordinary
shares of 10 pence each in the share capital of the Company
("Shares").
On 22 March 2022, Sharon O'Keefe, Non-Executive Director and
PDMR, purchased 3,200 Shares, held as American Depositary Receipts
(ADRs). Each ADR represents four ordinary shares of 10 pence in the
Company. Sharon O'Keefe's resulting shareholding is 3,200
Shares.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS
DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY
ASSOCIATED WITH THEM
1 Details of the person discharging managerial responsibilities/person
closely associated
a) Name Sharon O'Keefe
2 Reason for the notification
a) Position/Status Non-Executive Director
b) Initial notification/Amendment Initial notification
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
a) Name ConvaTec Group Plc
b) LEI 213800LS272L4FIDOH92
4 Details of the transaction(s): section to be repeated for
(i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions have
been conducted
a) Description of the financial Ordinary shares of 10p each in ConvaTec Group Plc
instrument, type of instrument GB00BD3VFW73
Identification code
b) Nature of the transaction American Depositary Receipts (ADRs), each representing
four ordinary shares of 10p each in
ConvaTec Group Plc
c) Price(s) and volume(s) Price(s) Volume(s)
$11.50 800
d) Aggregated information 800
- Aggregated volume $9,200
- Price
e) Date of the transaction 2022-03-22
f) Place of the transaction New York Stock Exchange (NYSE)
Enquiries
Analysts and Investors
Kate Postans, VP Investor Relations, ConvaTec +44 (0)782 644 7807
ir@convatec.com
Media
Buchanan: Charles Ryland / Chris Lane +44 (0)207 466 5000
ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92
About ConvaTec
ConvaTec is a global medical products and technologies company
focused on solutions for the management of chronic conditions, with
leading market positions in advanced wound care, ostomy care,
continence and critical care, and infusion care. Our products
provide a range of clinical and economic benefits including
infection prevention, protection of at-risk skin, improved patient
outcomes and reduced total cost of care. To learn more about
ConvaTec, please visit www.convatecgroup.com
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
DSHFLFEVVSIEFIF
(END) Dow Jones Newswires
March 25, 2022 10:00 ET (14:00 GMT)
Convatec (LSE:CTEC)
Historical Stock Chart
From Apr 2023 to May 2023
Convatec (LSE:CTEC)
Historical Stock Chart
From May 2022 to May 2023